Ricks:Yeah, all the time. I think maintaining energy for CEOs is a really important topic because when you walk in the door, badge in the building, you’re on and you’re not really off until you’re in your private space, which could be 14 hours later. For some people that’s ene...
David A. Ricks--Chair and Chief Executive Officer Yes. Thanks, Dan. So we had a strong financial performance in Q4 and throughout 2024. We finished $4 billion above our first-time revenue guide and $4 per share above our first-time EPS guide when taking IPR&D charges into account. The...
David A. Ricks Chairman, President & Chief Executive Officer Ralph Alvarez Independent Director Ruth Gimeno Vice President Gabrielle G. Greene-Sulzberger Independent Director Lucas E. Montarce Chief Financial Officer & Executive Vice President Katherine Baicker Independent DirectorSee All on Company & Peop...
But over time, Lilly’s work on less Street-pleasing pursuits, like diabetes and Alzheimer’s, began to bear fruit. Months before he became CEO in 2017, Ricks received a call from Skovronsky, who told him about a small study in Singapore involving an experimental compound to treat diabetes:...
Good morning. Thank you for joining us for Eli Lilly and Company's Q4 2021earnings callI'm Kevin Hern, vice president of investor relations. And joining me on today's call are Dave Ricks, Lilly's chair and CEO; Anat Ashkenazi, chief financial officer; Dr. ...
David A. Ricks Chairman, President & Chief Executive Officer Jon R. Moeller Director Ruth Gimeno Vice President Mary Lynne Hedley Independent Director Lucas E. Montarce Chief Financial Officer & Executive Vice President William G. Kaelin Jr. ...
Dave Ricks--Chairman and Chief Executive Officer Thanks, Jake. Paul, I think we've got time for maybe one more question. We're right at 11:00. So maybe a final question in the queue. Operator OK. And the final question today is coming from James Shin from Deutsche Bank. James, your...
David A. Ricks--Chair and Chief Executive Officer I would just add that actually unaided awareness for Zepbound, although we're -- everyone on this call is highly aware of the brand name, is actually not very high and that we launched this drug almost a year ago and have done no adver...
David A. Ricks--Chair and Chief Executive Officer Thanks, Joe. It's an exciting time here at Lilly as our growth trajectory accelerated in the second quarter. Our investments in advancing innovative medicine are focused on manufacturing expansion are bringing Lilly medicines to more people around ...